Institutional investors hold a majority ownership of ACT through the 86.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2013, these large investors purchased a net $676.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPPENHEIMERFUNDS, INC. Bought 2.5 Million shares of Actavis PLC
MORGAN STANLEY SMITH BARNEY LLC ... Bought 1.5 Million shares of Actavis PLC
OZ MANAGEMENT LP Bought 1.4 Million shares of Actavis PLC